CURAEM PHARMACEUTICALS

WHO WE ARE

We are a passionate team dedicated to helping individuals and brands grow through creative, strategic, and results-driven solutions.

DR ASHOK GNANASEKARAN

Associate Professor

Researcher

SATIA NARJADIN

Serial Entrepreneur

VC Investor

MISSION

To merge the natural sources of alternative medicine with technology and standards of modern medicine. To harvest the unique properties of medicinal plants and create drugs that can cure previously incurable diseases.

VISION

To find and produce natural solutions to incurable diseases

CURING LIVER DISEASES

Creating a drug from commonly grown plants that could help 300 million lives

  • Once a person develops a fatty liver from lifestyle issues, chronic liver problems can develop quickly. The organ will start dying.

  • Cirrhosis (pic 4) is extremely difficult to reverse. Hepatocellular carcinoma (HCC), or liver cancer cannot be reversed.

  • Our drug could supplement prevention and encourage the regeneration of the liver.

  • It will eliminate the need for invasive treatment.

PROBLEM

300,000,000

Nearly 300 million people worldwide are chronically infected with Hepatitis B. Currently there is no cure.

820,000

people die every year from Hepatitis B and related complications like liver cancer

100x

Hepatitis B is 100 times more infectious than the HIV/AIDS virus. It is also the primary cause of liver cancer.

0

specific treatments for acute Hepatitis B.

THE SOLUTION

We have successfully discovered multiple formulations from medicinal plants that can cure liver diseases caused by hepatitis B such as fibrosis and cirrhosis.

We are now seeking investment/funding to produce and distribute the drug, potentially saving millions

OUR ADVANTAGE

Modern drug development process (10-15 years; $1-1.5 bil) Our reverse pharmacology process (5-6 years; $2-20 mil) Reverse pharmacology eliminates drug discovery. We accelerate the process and slash costs.

We use naturally-sourced plants that will be cultivated under controlled environments, according to WHO standards.

We use naturally-sourced plants that will be cultivated under controlled environments, according to WHO standards.

PROJECT STAGES